Literature DB >> 2768373

Analysis of warfarin and its metabolites by reversed-phase ion-pair liquid chromatography with fluorescence detection.

Y W Wong1, P J Davis.   

Abstract

A high-performance liquid chromatographic method was developed for the determination of warfarin and its metabolites (diastereomeric warfarin alcohols and 6-, 7-, 8-, 4'- and 3'-hydroxywarfarin) in microbial cultures. Ion-pair chromatography with tetrabutylammonium ion as the counter ion allowed for the complete resolution of all compounds at pH 7.5 on a reversed-phase (C18) column, thus permitting direct fluorescence detection without the use of post-column pH switching techniques. Analysis of cell suspension cultures of the fungus Cunninghamella elegans (ATCC 36112) indicated that this organism metabolizes warfarin to all known mammalian metabolites, plus the previously unreported 3'-hydroxywarfarin. Detection limits for all compounds were in the low nanogram range.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2768373     DOI: 10.1016/s0021-9673(01)96463-5

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Microbial models of mammalian metabolism: stereoselective metabolism of warfarin in the fungus Cunninghamella elegans.

Authors:  Y W Wong; P J Davis
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

2.  Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin.

Authors:  E Chan; A J McLachlan; M Pegg; A D MacKay; R B Cole; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

3.  Measurement of warfarin in the oral fluid of patients undergoing anticoagulant oral therapy.

Authors:  Silvia Ghimenti; Tommaso Lomonaco; Massimo Onor; Laura Murgia; Aldo Paolicchi; Roger Fuoco; Lucia Ruocco; Giovanni Pellegrini; Maria Giovanna Trivella; Fabio Di Francesco
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

4.  Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.

Authors:  Harald Olsen; Anders Andersen; Arve Nordbø; Ulf E Kongsgaard; Ole P Børmer
Journal:  BMC Clin Pharmacol       Date:  2004-03-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.